US4193926A
(en)
|
1974-03-20 |
1980-03-18 |
Schering Aktiengesellschaft |
4-(Polyalkoxy phenyl)-2-pyrrolidones
|
DE2541855A1
(de)
*
|
1975-09-18 |
1977-03-31 |
Schering Ag |
4-(polyalkoxy-phenyl)-2-pyrrolidone ii
|
CU21107A3
(es)
|
1978-02-10 |
1988-02-01 |
Hoffmann La Roche |
Pyrrolidines derivatives
|
IL57266A
(en)
*
|
1978-06-12 |
1982-12-31 |
Mundipharma Ag |
Production of pyrrolidin-2-ones and of 3-pyrrolin-2-ones
|
IT1131959B
(it)
*
|
1979-08-09 |
1986-06-25 |
Hoffmann La Roche |
Derivati pirrolidinici
|
GB2123288A
(en)
*
|
1982-07-16 |
1984-02-01 |
Wellcome Found |
Anti-thrombotic agent
|
US4584313A
(en)
*
|
1984-05-07 |
1986-04-22 |
Warner-Lambert Company |
(Substituted-phenyl)-5-oxo-2-pyrrolidinepropanoic acids and esters thereof, and use for reversing electroconvulsive shock-induced amnesia
|
US4548947A
(en)
*
|
1984-05-07 |
1985-10-22 |
Warner-Lambert Company |
1-(Substituted-aryl)-dihydro-1H-pyrrolizine-3,5-[2H,6H-]diones and use for reversing amnesia
|
US5783591A
(en)
*
|
1984-10-19 |
1998-07-21 |
Schering Aktiengesellschaft |
Administration of oxazolidinone and pyrolidinone compounds for the treatment of inflammation
|
DE3438839A1
(de)
*
|
1984-10-19 |
1986-04-24 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Pharmazeutische praeparate
|
US5459145A
(en)
*
|
1988-01-19 |
1995-10-17 |
Pfizer Inc. |
Calcium independent camp phosphodiesterase inhibitor antidepressant
|
WO1987006576A1
(en)
*
|
1986-04-29 |
1987-11-05 |
Pfizer Inc. |
Calcium independent camp phosphodiesterase inhibitor antidepressant
|
FI875101A
(fi)
*
|
1986-12-03 |
1988-06-04 |
Tanabe Seiyaku Co |
Laktamderivat och preparat innehaollande dessa.
|
US5274002A
(en)
*
|
1987-04-14 |
1993-12-28 |
Warner-Lambert Company |
Trisubstituted phenyl analogs having activity for congestive heart failure
|
US4971959A
(en)
*
|
1987-04-14 |
1990-11-20 |
Warner-Lambert Company |
Trisubstituted phenyl analogs having activity for congestive heart failure
|
US4960457A
(en)
*
|
1988-12-27 |
1990-10-02 |
Ici Americas Inc. |
Substituted 1,3-diphenyl pyrrolidones and their use as herbicides
|
DE3921593A1
(de)
*
|
1989-06-28 |
1991-01-10 |
Schering Ag |
Verfahren zur racemattrennung von 4-aryl-2-oxo-pyrrolidin-3-carbonsaeure-ester
|
JP2578001B2
(ja)
*
|
1989-12-11 |
1997-02-05 |
明治製菓株式会社 |
抗痴呆薬
|
DE3943385A1
(de)
*
|
1989-12-27 |
1991-07-04 |
Schering Ag |
Mittel zur transdermalen applikation enthaltend rolipram
|
GB9009395D0
(en)
*
|
1990-04-26 |
1990-06-20 |
Orion Yhtymae Oy |
Cyclic hydroxamic acids and their use
|
DE69128627T2
(de)
*
|
1990-08-03 |
1998-07-02 |
Smithkline Beecham Corp |
Tnf-inhibitoren
|
DE4032055A1
(de)
*
|
1990-10-05 |
1992-04-09 |
Schering Ag |
Verfahren zur herstellung von optisch aktiven 4-aryl-2-pyrrolidinonen
|
US5547979A
(en)
*
|
1992-03-30 |
1996-08-20 |
Smithkline Beecham |
TNF inhibition
|
US5395935A
(en)
*
|
1992-05-08 |
1995-03-07 |
Pfizer Inc. |
Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
|
GB9212673D0
(en)
*
|
1992-06-15 |
1992-07-29 |
Celltech Ltd |
Chemical compounds
|
GB9222253D0
(en)
*
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
GB9226830D0
(en)
*
|
1992-12-23 |
1993-02-17 |
Celltech Ltd |
Chemical compounds
|
US5622977A
(en)
*
|
1992-12-23 |
1997-04-22 |
Celltech Therapeutics Limited |
Tri-substituted (aryl or heteroaryl) derivatives and pharmaceutical compositions containing the same
|
GB9304919D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
GB9304920D0
(en)
*
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
GB9312853D0
(en)
|
1993-06-22 |
1993-08-04 |
Euro Celtique Sa |
Chemical compounds
|
US5477611A
(en)
*
|
1993-09-20 |
1995-12-26 |
Tessera, Inc. |
Method of forming interface between die and chip carrier
|
US5665754A
(en)
*
|
1993-09-20 |
1997-09-09 |
Glaxo Wellcome Inc. |
Substituted pyrrolidines
|
ATE260911T1
(de)
*
|
1993-12-22 |
2004-03-15 |
Celltech R&D Ltd |
Trisubstituierte phenyl-derivate, verfahren zu deren herstellung und deren verwendung als phosphodiesterase (typ iv) hemmstoffe
|
GB9326173D0
(en)
*
|
1993-12-22 |
1994-02-23 |
Celltech Ltd |
Chemical compounds and process
|
CA2143143A1
(en)
*
|
1994-03-08 |
1995-09-09 |
Toshihiko Tanaka |
3-phenylpyrrolidine derivatives
|
US5338739A
(en)
*
|
1994-03-10 |
1994-08-16 |
Hoechst-Roussel Pharmaceuticals Inc. |
(Pyrrolidinyl)phenyl carbamates, compositions and use
|
US5786354A
(en)
*
|
1994-06-21 |
1998-07-28 |
Celltech Therapeutics, Limited |
Tri-substituted phenyl derivatives and processes for their preparation
|
US6245774B1
(en)
|
1994-06-21 |
2001-06-12 |
Celltech Therapeutics Limited |
Tri-substituted phenyl or pyridine derivatives
|
GB9412571D0
(en)
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412573D0
(en)
*
|
1994-06-22 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
GB9412672D0
(en)
*
|
1994-06-23 |
1994-08-10 |
Celltech Ltd |
Chemical compounds
|
US5922751A
(en)
|
1994-06-24 |
1999-07-13 |
Euro-Celtique, S.A. |
Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
|
US5591776A
(en)
*
|
1994-06-24 |
1997-01-07 |
Euro-Celtique, S.A. |
Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV
|
US5665737B1
(en)
*
|
1994-10-12 |
1999-02-16 |
Euro Celtique Sa |
Substituted benzoxazoles
|
US6025361A
(en)
|
1994-12-13 |
2000-02-15 |
Euro-Celtique, S.A. |
Trisubstituted thioxanthines
|
US6066641A
(en)
*
|
1994-12-13 |
2000-05-23 |
Euro-Celtique S.A. |
Aryl thioxanthines
|
JPH11500110A
(ja)
*
|
1995-02-10 |
1999-01-06 |
シエーリング アクチエンゲゼルシヤフト |
Tnf−抑制用製剤
|
US6268373B1
(en)
|
1995-06-07 |
2001-07-31 |
Euro-Celtique S.A. |
Trisubstituted thioxanthines
|
US6166041A
(en)
|
1995-10-11 |
2000-12-26 |
Euro-Celtique, S.A. |
2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
|
DE19540475A1
(de)
*
|
1995-10-20 |
1997-04-24 |
Schering Ag |
Chirale Methylphenyloxazolidinone
|
GB9523675D0
(en)
|
1995-11-20 |
1996-01-24 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526245D0
(en)
*
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526243D0
(en)
*
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9526246D0
(en)
*
|
1995-12-21 |
1996-02-21 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6075016A
(en)
|
1996-04-10 |
2000-06-13 |
Euro-Celtique S.A. |
6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity
|
GB9608435D0
(en)
*
|
1996-04-24 |
1996-06-26 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US5864037A
(en)
|
1996-06-06 |
1999-01-26 |
Euro-Celtique, S.A. |
Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity
|
JP4017214B2
(ja)
|
1996-06-11 |
2007-12-05 |
興和創薬株式会社 |
5−フェニル−3−ピリダジノン誘導体
|
WO1998004534A1
(fr)
|
1996-07-31 |
1998-02-05 |
Nikken Chemicals Co., Ltd. |
Derives de 6-phenyltetrahydro-1,3-oxazine-2-one et compositions medicinales a base de ces composes
|
WO1998008828A1
(fr)
|
1996-08-27 |
1998-03-05 |
Nikken Chemicals Co., Ltd. |
Derives du 2-phenylmorpholin-5-one et composition pharmaceutique les comprenant
|
US5744473A
(en)
*
|
1996-09-16 |
1998-04-28 |
Euro-Celtique, S.A. |
PDE IV inhibitors: "bis-compounds"
|
GB9619284D0
(en)
*
|
1996-09-16 |
1996-10-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9622363D0
(en)
*
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9625184D0
(en)
*
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
JP2001507349A
(ja)
|
1996-12-23 |
2001-06-05 |
セルテック セラピューティックス リミテッド |
縮合多環式2−アミノピリミジン誘導体、それらの製造およびたんぱく質チロシンキナーゼ抑制因子としてのそれらの使用
|
GB9705361D0
(en)
*
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9713087D0
(en)
*
|
1997-06-20 |
1997-08-27 |
Celltech Therapeutics Ltd |
Chemical compounds
|
US6235736B1
(en)
|
1997-06-24 |
2001-05-22 |
Nikken Chemicals Co., Ltd. |
3-anilino-2-cycloalkenone derivatives
|
EP1043324B1
(en)
|
1997-11-12 |
2004-06-16 |
Mitsubishi Chemical Corporation |
Purine derivatives and medicine containing the same as the active ingredient
|
US6232297B1
(en)
*
|
1999-02-01 |
2001-05-15 |
University Of Virginia Patent Foundation |
Methods and compositions for treating inflammatory response
|
US7427606B2
(en)
|
1999-02-01 |
2008-09-23 |
University Of Virginia Patent Foundation |
Method to reduce inflammatory response in transplanted tissue
|
US7378400B2
(en)
|
1999-02-01 |
2008-05-27 |
University Of Virginia Patent Foundation |
Method to reduce an inflammatory response from arthritis
|
KR100747106B1
(ko)
*
|
1999-05-11 |
2007-08-08 |
미쯔비시 가가꾸 가부시끼가이샤 |
퓨린 유도체 이수화물, 이를 유효성분으로 함유하는 의약및 이의 제조 중간체
|
GB9914258D0
(en)
*
|
1999-06-18 |
1999-08-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
CA2715683A1
(en)
|
1999-08-21 |
2001-03-01 |
Nycomed Gmbh |
Synergistic combination
|
GB9924862D0
(en)
|
1999-10-20 |
1999-12-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
EP1270577B1
(en)
*
|
2000-03-23 |
2006-12-06 |
Takeda Pharmaceutical Company Limited |
Furoisoquinoline derivatives, process for producing the same and use thereof
|
JP4291135B2
(ja)
*
|
2001-05-29 |
2009-07-08 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
Cdk阻害性ピリミジン、それらの製造および薬剤としての使用
|
ATE517663T1
(de)
*
|
2001-07-16 |
2011-08-15 |
Merck Patent Gmbh |
Photostabile organische sonnenschutzverbindungen mit antioxidationseigenschaften und daraus gewonnene zusammensetzungen
|
NZ556354A
(en)
|
2001-10-01 |
2008-10-31 |
Univ Virginia |
2-Propynyl adenosine analogs having A2A agonist activity and compositions thereof
|
RU2340600C2
(ru)
*
|
2001-10-16 |
2008-12-10 |
Мемори Фармасьютиклз Корпорейшн |
Производные 4-(4-алкокси-3-гидроксифенил)-2-пирролидона в качестве ингибиторов pde-4 для лечения неврологических синдромов
|
JP2006515829A
(ja)
*
|
2002-04-10 |
2006-06-08 |
ユニバーシティ オブ バージニア パテント ファウンデーション |
炎症性疾病の処置のための、a2aアデノシン受容体アゴニストの使用
|
KR20050026014A
(ko)
*
|
2002-07-26 |
2005-03-14 |
다케다 야쿠힌 고교 가부시키가이샤 |
푸로이소퀴놀린 유도체 및 이의 용도
|
US7495016B2
(en)
*
|
2002-10-21 |
2009-02-24 |
Irm Llc |
Pyrrolidones with anti-HIV activity
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
AU2004226353A1
(en)
|
2003-04-01 |
2004-10-14 |
Laboratoires Serono Sa |
Inhibitors of phosphodiesterases in infertility
|
EP1613590A2
(en)
*
|
2003-04-16 |
2006-01-11 |
Memory Pharmaceutical Corporation |
4-(3,4-disubstituted phenyl)-pyrrolidin-2-one compounds as phosphodiesterase 4 inhibitors
|
WO2004094411A1
(en)
*
|
2003-04-18 |
2004-11-04 |
Memory Pharmaceuticals Corporation |
Pyrazole derivatives as phosphodiesterase 4 inhibitors
|
CA2523356A1
(en)
*
|
2003-04-25 |
2004-11-11 |
Icos Corporation |
Method of preparing a ring compound having two adjacent chiral centers
|
AU2005243384A1
(en)
*
|
2004-05-17 |
2005-11-24 |
Otsuka Pharmaceutical Co., Ltd. |
Thiazole compound and use thereof
|
WO2006023272A1
(en)
|
2004-08-02 |
2006-03-02 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having a2a agonist activity
|
US7576069B2
(en)
|
2004-08-02 |
2009-08-18 |
University Of Virginia Patent Foundation |
2-polycyclic propynyl adenosine analogs having A2A agonist activity
|
EP1778712B1
(en)
*
|
2004-08-02 |
2013-01-30 |
University Of Virginia Patent Foundation |
2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
|
WO2006044528A1
(en)
*
|
2004-10-15 |
2006-04-27 |
Memory Pharmaceuticals Corporation |
Pyrazole derivatives as phosphodiesterase 4 inhibitors
|
CN101166737A
(zh)
*
|
2004-10-20 |
2008-04-23 |
记忆药物公司 |
磷酸二酯酶4抑制剂
|
WO2007120972A2
(en)
*
|
2006-02-10 |
2007-10-25 |
University Of Virginia Patent Foundation |
Method to treat sickle cell disease
|
US8188063B2
(en)
*
|
2006-06-19 |
2012-05-29 |
University Of Virginia Patent Foundation |
Use of adenosine A2A modulators to treat spinal cord injury
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
ES2393885T7
(es)
|
2007-06-04 |
2014-01-30 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
US8058259B2
(en)
|
2007-12-20 |
2011-11-15 |
University Of Virginia Patent Foundation |
Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
WO2010075086A2
(en)
*
|
2008-12-15 |
2010-07-01 |
Auspex Pharmaceuticals, Inc. |
Pyrrolidinone inhibitors of pde-4
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
JP6251038B2
(ja)
|
2011-03-01 |
2017-12-20 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼcアゴニストの調製方法
|
ES2395801B1
(es)
|
2011-06-23 |
2014-06-06 |
María Carmen PARDINA PALLEJÀ |
"pentoxifilina por vía transvaginal para el tratamiento de la infertilidad"
|
AU2014218599C1
(en)
|
2013-02-25 |
2018-09-06 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists for use in colonic cleansing
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
JP2016514671A
(ja)
|
2013-03-15 |
2016-05-23 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼのアゴニストおよびその使用
|
US10011637B2
(en)
|
2013-06-05 |
2018-07-03 |
Synergy Pharmaceuticals, Inc. |
Ultra-pure agonists of guanylate cyclase C, method of making and using same
|
JP6694385B2
(ja)
|
2013-08-09 |
2020-05-13 |
アーデリクス,インコーポレーテッド |
リン酸塩輸送阻害のための化合物及び方法
|
JP2022533251A
(ja)
|
2019-05-21 |
2022-07-21 |
アルデリックス, インコーポレイテッド |
患者において血清リン酸塩を低下させるための組み合わせ
|